Performance status-2 - Symptomatic, 50 in bed - Page 7 of 12 Posts on Medivizor
Navigation Menu

Performance status-2 – Symptomatic, 50 in bed Posts on Medivizor

Weight loss in overweight or obese breast cancer survivors reduces hormonal factors that influence the risk of cancer recurrence

Weight loss in overweight or obese breast cancer survivors reduces hormonal factors that influence the risk of cancer recurrence

Posted by on Jul 4, 2013 in Breast cancer | 0 comments

In a nutshell This study investigated how weight loss affects hormonal factors in breast cancer survivors. The levels of hormones which are thought to increase the risk of recurrence were compared before and after weight loss. Some background Overweight status and obesity have been shown to increase the risk of recurrence and lower survival in...

Read More

Comparing survival after mastectomy and lumpectomy in patients with early-stage breast cancer

Posted by on Jun 28, 2013 in Breast cancer | 0 comments

In a nutshell The study compared survival rates in patients with early stage breast cancer treated with mastectomy versus lumpectomy plus radiation therapy. Some background Most breast cancers grow in response to female hormones (estrogen or progesterone), via their receptor (a protein found on the surface of the cancer cells). These cancers are...

Read More

Wait-and-see policy in patients with rectal cancer treated with chemoradiotherapy

Wait-and-see policy in patients with rectal cancer treated with chemoradiotherapy

Posted by on Jun 26, 2013 in Colorectal cancer | 0 comments

In a nutshell The purpose of this study was to evaluate the safety and utility of a wait and see policy in patients with rectal cancer treated with chemoradiotherapy.  Some background Treatment options for patients with rectal cancer (cancer in the final part of the large bowel) is chemotherapy with or without radiotherapy (together called...

Read More

Are there any benefits to continuing trastuzumab after disease progression in patients with HER2+ metastatic breast cancer?

Are there any benefits to continuing trastuzumab after disease progression in patients with HER2+ metastatic breast cancer?

Posted by on Jun 25, 2013 in Breast cancer | 0 comments

In a nutshell This article evaluated the benefits of continuing trastuzumab treatment after disease progression in patients with HER2+ metastatic (spread to distant organs and tissues) breast cancer. Some background Breast cancer cells have on their surface some proteins called receptors. Hormones bind to these receptors causing changes in the...

Read More

Phase 3 clinical trial evaluating the safety and efficacy of high-dose 5-fluorouracil given in continuous injection in patients with stage III colon cancer

Phase 3 clinical trial evaluating the safety and efficacy of high-dose 5-fluorouracil given in continuous injection in patients with stage III colon cancer

Posted by on Jun 16, 2013 in Colorectal cancer | 0 comments

In a nutshell This study compared the efficacy and safety of continuous injection high-dose 5-fluorouracil (HD-FU) versus standard dose bolus (rapid injection into the vein) 5-fluorouracil (FU) for the treatment of patients with stage III colon cancer. Some background Colon cancer is caused by an uncontrolled growth of cells in the large...

Read More

Can anemia at diagnosis predict the course of the treatment and survival in patients with rectal cancer?

Can anemia at diagnosis predict the course of the treatment and survival in patients with rectal cancer?

Posted by on Jun 14, 2013 in Colorectal cancer | 0 comments

In a nutshell This study investigated the association between hemoglobin or Hb (a protein found in the blood that carries oxygen to the tissues of the body) levels at the time of cancer diagnosis, response to treatment and long-term outcomes in patients with rectal cancer. Some background Rectal cancer is caused by an uncontrolled cell growth in...

Read More

Phase 3 clinical trial comparing the addition of anastrozole versus tamoxifen to goserelin therapy before surgery for patients with early-stage breast cancer

Phase 3 clinical trial comparing the addition of anastrozole versus tamoxifen to goserelin therapy before surgery for patients with early-stage breast cancer

Posted by on Jun 5, 2013 in Breast cancer | 0 comments

In a nutshell This phase 3 clinical trial compared the safety and efficacy of two different combination treatments in women with early stage breast cancer: anastrozole (Arimidex) plus goserelin (Zoladex) versus tamoxifen (Nolvadex) plus goserelin. Some background An estrogen-receptor positive (ER+) breast cancer requires estrogen (the primary...

Read More

Phase II clinical trial evaluating the effects of anti-inflammatory drug celecoxib as treatment for breast cancer patients

Phase II clinical trial evaluating the effects of anti-inflammatory drug celecoxib as treatment for breast cancer patients

Posted by on Jun 1, 2013 in Breast cancer | 0 comments

In a nutshell This phase II clinical trial evaluated the effect of the drug celecoxib (Celebrex) as treatment for patients with breast cancer.  Some background Inflammation is one of the body's natural responses to injury and may play a role in cancer formation. Inflammation is controlled in part by a type of hormone produced by cells...

Read More

Does breast cancer type and hormone status influence the efficacy of hormone therapy in breast cancer patients?

Posted by on Jun 1, 2013 in Breast cancer | 0 comments

In a nutshell This study evaluated the efficacy of hormone therapy in patients with two types of breast cancer, invasive ductal breast carcinomas (IDC) and invasive lobular breast carcinomas (ILC) based on hormonal status.  Some background Breasts are made up of lobules (milk-producing glands) and ducts (tubes that carry the milk to the...

Read More